Drugs / ARC-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06864884 | Feb 2025 → Feb 2026 overdue | impacted teeth, multiple | Arcato Laboratories, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARC-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06864884 ↗ |
| Route | Topical | “0.75 mL gel emulsion with active ingredient applied once to the surgical site.” NCT06864884 ↗ |